Novel muteins of human tumor necrosis factor with potent antitumor activity and less lethal toxicity in mice
Authors:
- 27 September 1995
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 63 (1) , 152-157
Abstract
Eight muteins of recombinant human tumor necrosis factor-α (rhTNF; SSSRTP … 29RR … 155L), in which 29Arg was replaced by another amino acid, were prepared and their anti-tumor effects in BALB/c mice bearing Meth A fibrosarcoma were evaluated. The therapeutic indices, which mark the extent of the therapeutically effective dose, of V29 (29Arg ± Val) and D29 (± Asp) were 3.5 and 3.2, respectively, whereas that of rhTNF was 1.4. Clearly, the therapeutically effective range of these muteins was extended along with a decrease in lethal toxicity. V29 did not produce hypotension in the rat system, but D29 did. In addition, V29 showed potent anti-tumor activity (Tumor Volume Inhibition Rate = 81% on day 15 after implantation) in 3 consecutive injection schedules despite the decreases in toxicity compared with rhTNF. The relative receptor binding constant was determined using HEp-2 cells (expressing mainly 55-kDa-TNF receptor; p55R) and HL60 cells (expressing mainly 75-kDa-TNF receptor; p75R), and revealed that the reduced toxicity of V29 in mice was due to the reduced binding to p55R (34% of rhTNF). On the other hand, the ratio of the constants HEp-2/HL60 of V29 was 11 in comparison with the value of 1.0 for rhTNF, suggesting that this mutein binds preferentially to p55R. The biological activities in human cell lines (HEp-2 and HL60 cells) correlated well with the binding activities to each receptor in vitro. Therefore, the much lower toxicity and the potent anti-tumor activity of this mutein suggest that V29 merits further investigation in pre-clinical and clinical trials.Keywords
This publication has 29 references indexed in Scilit:
- A human tumor necrosis factor (TNF) alpha mutant that binds exclusively to the p55 TNF receptor produces toxicity in the baboon.Journal of Experimental Medicine, 1994
- Lymphotoxin Lacks Effects on 75-kDa Receptors in Cytotoxicity on U-937 CellsBiochemical and Biophysical Research Communications, 1994
- Mice lacking the tumour necrosis factor receptor 1 are resistant to IMF-mediated toxicity but highly susceptible to infection by Listeria monocytogenesNature, 1993
- Human TNF mutants with selective activity on the p55 receptorNature, 1993
- Functional characterization of the human tumor necrosis factor receptor p75 in a transfected rat/mouse T cell hybridoma.Journal of Experimental Medicine, 1992
- Two TNF receptorsImmunology Today, 1992
- Four different interleukin-1 species sensitize to the lethal action of Tumour Necrosis FactorBiochemical and Biophysical Research Communications, 1989
- Identity of differentiation inducing factor and tumour necrosis factorNature, 1986
- Tumor necrosis factor provokes superoxide anion generation from neutrophilsBiochemical and Biophysical Research Communications, 1986
- Evidence that types I and II interferons have different receptorsNature, 1981